Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-31

FDA Approved: GLIMEPIRIDE — Supplemental Application (Accord Healthcare Inc)

View source ↗

Summary

The FDA approved a supplemental application for glimepiride by Accord Healthcare Inc, authorizing changes to the approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glimepiride (glimepiride)

Snippet

SUPPL AP for GLIMEPIRIDE (GLIMEPIRIDE)